TPCW
AMPH icon

TD Private Client Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History

TD Private Client Wealth’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48K Hold
2,379
– – ﹤0.01% 898
2026
Q1 		$46.6K Sell
2,379
-39
-2% -$954 ﹤0.01% 892
2025
Q4 		$64.8K Buy
2,418
+1,944
+410% +$50.1K ﹤0.01% 842
2025
Q3 		$12.6K Sell
474
-1,221
-72% -$31.5K ﹤0.01% 1050
2025
Q2 		$38.9K Sell
1,695
-32
-2% -$794 ﹤0.01% 885
2025
Q1 		$50.1K Sell
1,727
-372
-18% -$11.9K ﹤0.01% 811
2024
Q4 		$77.9K Buy
2,099
+388
+23% +$17.7K ﹤0.01% 749
2024
Q3 		$83K Buy
1,711
+39
+2% +$1.71K ﹤0.01% 740
2024
Q2 		$66.9K Buy
1,672
+16
+1% +$663 ﹤0.01% 755
2024
Q1 		$72.7K Buy
1,656
+412
+33% +$21.3K ﹤0.01% 747
2023
Q4 		$76.9K Buy
1,244
+208
+20% +$10.9K ﹤0.01% 733
2023
Q3 		$47.6K Hold
1,036
– – ﹤0.01% 777
2023
Q2 		$59.5K Buy
1,036
+428
+70% +$19K ﹤0.01% 747
2023
Q1 		$22.8K Buy
608
+119
+24% +$3.9K ﹤0.01% 921
2022
Q4 		$13.7K Sell
489
-120
-20% -$3.48K ﹤0.01% 968
2022
Q3 		$17.1K Hold
609
– – ﹤0.01% 933
2022
Q2 		$21.2K Buy
609
+173
+40% +$6.17K ﹤0.01% 909
2022
Q1 		$15.7K Buy
+436
New +$12.4K ﹤0.01% 983

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

TD Private Client Wealth's AMPH Position: Q2 2026 in Review

TD Private Client Wealth held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 2,379 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

TD Private Client Wealth first reported a position in AMPH in Q1 2022 and has held it in 18 quarters since. The position peaked at $83K in Q3 2024. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • TD Private Client Wealth held 2,379 shares of Amphastar Pharmaceuticals worth $48K as of Q2 2026.
  • TD Private Client Wealth left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #898 holding.
  • TD Private Client Wealth first reported a position in Amphastar Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • TD Private Client Wealth's Amphastar Pharmaceuticals position peaked at $83K in Q3 2024.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.